-
CONTRACEPTION PREFERENCES OF WOMEN AND HEALTHCARE PROVIDERS: A DISCRETE CHOICE EXPERIMENT
Feb 25, 2026, 14:42 PM -
TREATMENT AND RECURRENCE PATTERNS AMONG BACILLUS CALMETTE-GUÉRIN EXPERIENCED PATIENTS WITH RECURRENT, PAPILLARY-ONLY HIGH-RISK NON-MUSCLE INVASIVE BLADDER CANCER
Feb 25, 2026, 14:42 PM -
ESTIMATING THE HEALTH OPPORTUNITY COST OF PUBLIC HEALTH EXPENDITURE IN KAZAKHSTAN: EMPIRICAL SUPPLY-SIDE COST-EFFECTIVENESS THRESHOLDS
Feb 25, 2026, 14:42 PM -
REVIEW OF CEESP ICERS FOR ORPHAN AND NON-ORPHAN TREATMENTS IN FRANCE, 2024 - 2025
Feb 25, 2026, 14:42 PM -
RETHINKING HEALTH ECONOMIC MODELS FOR OUTCOME-ALIGNED PAYMENTS: A FRAMEWORK FOR THE NEW 2026 CMS ACCESS MODEL
Feb 25, 2026, 14:42 PM -
ECONOMIC IMPACT OF ADDING TALAZOPARIB TO ENZALUTAMIDE IN PATIENTS WITH HRRM MCRPC
Feb 25, 2026, 14:42 PM -
USE OF REAL-TIME AI-ASSISTED LIVING SYSTEMATIC LITERATURE REVIEW (REAL-SLR) IN PROSTATE CANCER (PC) ENABLES ON-DEMAND ACCESS TO PIVOTAL CLINICAL TRIAL EVIDENCE
Feb 25, 2026, 14:42 PM -
ACCOUNTING FOR RISK-AVERSION IN HEALTH TECHNOLOGY ASSESSMENT: UTILITY ESTIMATION ACROSS MULTIPLE HEALTH INDEXES IN NON-SMALL CELL LUNG CANCER
Feb 25, 2026, 14:42 PM -
OPTIMIZING ENDPOINTS FOR CRSWNP BIOLOGIC TRIALS: REGULATORY, HTA, AND PATIENT-CENTERED EVIDENCE REQUIREMENTS
Feb 25, 2026, 14:42 PM -
EFFECT OF ANTIHYPERTENSIVE USE ON FALL RISK
Feb 25, 2026, 14:42 PM -
ADALIMUMAB BIOSIMILAR UPTAKE IN US MEDICAID: AN ANALYSIS OF MANAGED CARE VS. FEE-FOR-SERVICE EXPENDITURE TRENDS (2024-2025)
Feb 25, 2026, 14:42 PM -
REAL-WORLD HEALTHCARE RESOURCE UTILIZATION AND COSTS OF HOSPITAL-ONSET METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS BLOODSTREAM INFECTIONS IN U.S. HOSPITALS: 2023-2025
Feb 25, 2026, 14:42 PM -
DISMANTLING BARRIERS IN PATIENT-LED RESEARCH: UTILIZING AN AI-ENHANCED ACCESS-CENTERED RESEARCH MODEL TO EVALUATE THE INTEGRATION OF PATIENT-REPORTED OUTCOMES IN FDA ORPHAN DRUG APPROVALS
Feb 25, 2026, 14:42 PM -
ETHICAL AI DEPLOYMENT IN HEOR
Feb 25, 2026, 14:42 PM -
CAN AI LEARN PATIENT PREFERENCES? PREDICTING PATIENT PREFERENCE HETEROGENEITY USING LARGE LANGUAGE MODELS
Feb 25, 2026, 14:42 PM -
ARCHITECTURE OF RARE-DISEASE MODELS: STRUCTURAL CHOICES AND CLINICAL TRIAL ENDPOINT USE IN NICE HST EVALUATIONS
Feb 25, 2026, 14:42 PM -
GIVE ME THE NUMBERS: FINE-GRAINED, STRUCTURED DATA EXTRACTION BEYOND NARRATIVE LLM OUTPUTS
Feb 25, 2026, 14:42 PM -
EFFECT OF CHINESE HERBAL MEDICINE COMBINED WITH CONVENTIONAL ANTI-OSTEOPOROTIC MEDICATION ON FRACTURE RISK IN OLDER ADULTS WITH OSTEOPOROSIS: A RETROSPECTIVE COHORT STUDY
Feb 25, 2026, 14:42 PM -
REPOSITIONING HEOR AS A RISK MITIGATION TOOL FOR HEALTHCARE INVESTMENT DECISION-MAKING: GOOD VALUE FOR MONEY?
Feb 25, 2026, 14:42 PM -
A FEDERATED ANALYSIS OF CLINICAL REAL-WORLD DATA LINKING TREATMENT PERSISTENCE AND SOCIO-ECONOMIC OUTCOMES IN MULTIPLE SCLEROSIS ACROSS DIFFERENT HEALTHCARE SYSTEMS
Feb 25, 2026, 14:42 PM
